Calliditas Therapeutics AB - ADR(NASDAQ:CALT) 
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a unique formulation optimized to...
Website: https://www.calliditas.se/
Founded: 2004
Full Time Employees: 23
CEO: Renée Julie Elisabet Aguiar-Lucander
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-18
P
O 38.75
H 39.02
L 38.62
C 38.62
V 4,214
10EMA 38.62
20EMA 38.62
60EMA 38.62
120EMA 38.62
250EMA 38.62